Intelligent Bio Solutions...

NASDAQ: INBS · Real-Time Price · USD
1.46
-0.02 (-1.35%)
At close: Aug 15, 2025, 12:13 PM

Intelligent Bio Solutions Balance Sheet Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
Cash & Equivalents
6.3M 1.54M 8.24M 12.57M
Short-Term Investments
n/a 118.19K 46.6K n/a
Long-Term Investments
n/a n/a 1.09M 3.15M
Other Long-Term Assets
n/a n/a n/a 866.67K
Receivables
978.35K 833.16K 2.47M 3.21M
Inventory
777.54K 979.91K n/a -3.21M
Other Current Assets
111.19K 34.1K n/a n/a
Total Current Assets
8.53M 3.86M 10.87M 16.39M
Property-Plant & Equipment
872.59K 1.24M 391.41K n/a
Goodwill & Intangibles
4.37M 5.26M n/a n/a
Total Long-Term Assets
5.24M 6.49M 1.48M 4.01M
Total Assets
13.78M 10.35M 12.35M 20.4M
Account Payables
602.34K 1.2M 715.9K 1.36M
Deferred Revenue
2.49M 2.34M 2.84M 2.1M
Short-Term Debt
790.12K 576.66K n/a n/a
Other Current Liabilities
332.34K 1.19M 3.75M 2.22M
Total Current Liabilities
5.45M 5.88M 4.66M 3.68M
Long-Term Debt
n/a 759.03K n/a n/a
Other Long-Term Liabilities
63.62K -331.26K 50.63K 21.77K
Total Long-Term Liabilities
144.94K 783.93K 1.14M 3.17M
Total Liabilities
5.6M 6.67M 5.81M 6.85M
Total Debt
871.44K 1.34M n/a n/a
Common Stock
34.56K 23.3K 148.9K 142.32K
Retained Earnings
-51.96M -41.81M -31.18M -24.32M
Comprehensive Income
-712.61K -575.5K -788.13K -661.26K
Shareholders Equity
8.33M 3.8M 6.62M 13.61M
Total Investments
n/a 118.19K 1.09M 3.15M